Zhejiang Shengda Bio-Pharm Co Ltd Class A 603079
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 13.96
- Day Range
- CNY 12.91–14.28
- 52-Week Range
- CNY 7.01–16.24
- Bid/Ask
- CNY 13.51 / CNY 13.52
- Market Cap
- CNY 2.31 Bil
- Volume/Avg
- 19.3 Mil / 7.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.25
- Dividend Yield (Trailing)
- 0.44%
- Dividend Yield (Forward)
- 0.44%
- Total Yield
- 0.44%
Company Profile
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,152
- Website
- http://www.sd-pharm.com
Comparables
Valuation
|
Metric
|
603079
|
000915
|
002433
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 14.59 | — |
Price/Book Value | 1.92 | 2.68 | 1.03 |
Price/Sales | 3.25 | 3.38 | 1.16 |
Price/Cash Flow | 22.69 | 7.90 | — |
Price/Earnings
603079
000915
002433
Financial Strength
|
Metric
|
603079
|
000915
|
002433
|
|---|---|---|---|
Quick Ratio | 1.84 | — | 0.23 |
Current Ratio | 2.95 | — | 0.49 |
Interest Coverage | −15.66 | — | −10.04 |
Quick Ratio
603079
000915
002433
Profitability
|
Metric
|
603079
|
000915
|
002433
|
|---|---|---|---|
Return on Assets (Normalized) | −1.51% | 11.61% | −20.42% |
Return on Equity (Normalized) | −1.90% | 20.00% | −46.06% |
Return on Invested Capital (Normalized) | −1.84% | 13.38% | −26.92% |
Return on Assets
603079
000915
002433
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Bldyyqrmfk | Drvth | $76.9 Bil | |
MKKGY
| Merck KGaA ADR | Vbbtcyvph | Ddwcw | $72.0 Bil | |
HLN
| Haleon PLC ADR | Xpsylhd | Tvxhr | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Cptxvbb | Pkwbr | $17.8 Bil | |
VTRS
| Viatris Inc | Gnnzwvhb | Shxh | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ljjwrxpy | Mgpr | $12.5 Bil | |
CTLT
| Catalent Inc | Vhmkrstq | Nwshfd | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Wvvzwpys | Nnds | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Bykdnygf | Skz | $3.9 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bsqnphrrt | Vqlpln | $3.5 Bil |